Both in Pharmaceuticals
Travere Therapeutics vs Arcutis Biotherapeutics
Over the past year TVTX returned +51.7% and ARQT returned +34.6%; their daily moves had a correlation of 0.38.
TVTX +51.7% ARQT +34.6%Growth of $1, one year, split-adjusted
| Metric | TVTX | ARQT |
|---|---|---|
| Price | $52.40 | $33.32 |
| Market cap | $4.94B | $4.19B |
| Today | +6.04% | +4.11% |
| 1 month | −6.4% | +39.3% |
| 6 months | +17.1% | +37.8% |
| Year to date | +37.1% | +14.7% |
| 1 year | +51.7% | +34.6% |
| Revenue growth (YoY) | +36.2% | +59.3% |
| Gross margin | 98.7% | 91.6% |
| Net margin | −23.3% | 11.6% |
| P/E (TTM) | — | 146.8× |
| Price / sales | 7.6× | 9.0× |
| Net cash | -$131.7M | $129.7M |
| Dividend yield | — | — |
| Volatility (60d) | 37.7% | 54.0% |
| Short % of float | 12.1% | 18.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).